Therapeutic Kinase Inhibitors
Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as “chemotherapy” and still the backbone of most cancer treatment regimens, are increasingly being complemented by or repl...
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Mellinghoff, Ingo K. (Επιμελητής έκδοσης), Sawyers, Charles L. (Επιμελητής έκδοσης) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2012.
|
Σειρά: | Current Topics in Microbiology and Immunology,
355 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Resistance to Tyrosine Kinase Inhibitors
Έκδοση: (2016) -
STAT Inhibitors in Cancer
Έκδοση: (2016) -
Phosphoinositide 3-kinase in Health and Disease Volume 2 /
Έκδοση: (2011) -
Proteases and Their Inhibitors in Cancer Metastasis
Έκδοση: (2002) -
Protein Kinase C in Cancer Signaling and Therapy
Έκδοση: (2010)